Examples of using Clinically relevant differences in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
There were no clinically relevant differences in Cmax compared to healthy volunteers.
The analysis of the impact of NSCLC histology on overall survival demonstrated clinically relevant differences in survival according to histology, see table below.
Analiza utjecaja histologije NSCLC-a na ukupno preživljenje pokazala je klinički značajnu razliku u preživljenju s obzirom na histološki tip tumora, vidjeti tablicu ispod.There are no clinically relevant differences in the pharmacokinetics of brivaracetam by gender.
Nema klinički značajnih razlika u farmakokinetici brivaracetama s obzirom na spol.Based on pharmacokinetic data from a study in Japanese patients with prostate cancer,there were no clinically relevant differences in exposure between Japanese and Caucasians.
Na temelju farmakokinetičkih podataka dobivenih tijekom ispitivanja na japanskim bolesnicima s karcinomom prostate,nije bilo klinički značajne razlike u izloženosti između Japanaca i bijelaca.Elderly: There are no clinically relevant differences due to age in the pharmacokinetics of cinacalcet.
Stariji: Nema relevantnih kliničkih razlika farmakokinetike sinakalceta zbog dobi.A population PK analysis did not identify clinically relevant differences in PK of cabozantinib based on race.
Populacijska PK analiza nije otkrila klinički značajne razlike u PK kabozantiniba na temelju rase.No clinically relevant differences in aprepitant pharmacokinetics is expected due to age and gender.
Ne očekuju se nikakve klinički značajne razlike u farmakokinetici aprepitanta između dobnih skupina i spolova.Dapagliflozin: There were no clinically relevant differences in systemic exposures between White, Black or Asian races.
Dapagliflozin: Nije bilo klinički značajnih razlika u sistemskoj izloženosti između bijelaca, crnaca i azijata.No clinically relevant differences in the pharmacokinetics of rilpivirine have been observed between men and women.
Nisu primijećene klinički značajne razlike u farmakokinetici rilpivirina između muškaraca i žena.There were no clinically relevant differences in the clearance of tigecycline between men and women.
Ne postoje klinički relevantne razlike u klirensu tigeciklina između muškaraca i žena.There are no clinically relevant differences between genders in pharmacokinetic properties of Levemir.
Nisu utvrđene klinički značajne razlike u farmakokinetičkim svojstvima lijeka Levemir između spolova.There were no clinically relevant differences in systemic exposures between White, Black or Asian races.
Nije bilo klinički značajnih razlika u sustavnoj izloženosti između ispitanika bijele, crne i azijske rase.There were no clinically relevant differences observed in saxagliptin pharmacokinetics between males and females.
Nisu primijećene klinički značajne razlike u farmakokinetici saksagliptina između muškaraca i žena.There were no clinically relevant differences in systemic exposures between White, Black or Asian races.
Nije bilo klinički značajnih razlika u sustavnoj izloženosti između bijelaca, crnaca i ispitanika azijskog podrijetla.There were no clinically relevant differences observed for the safety profile of pemetrexed within the histology subgroups.
Nije bilo klinički značajnih razlika u sigurnosnom profilu pemetrekseda unutar histoloških podskupina.There were no clinically relevant differences in pharmacokinetics and pharmacodynamics between male and female patients.
Nisu uočene klinički značajne razlike ni u farmakokinetici ni u farmakodinamici između bolesnika i bolesnica.There were no clinically relevant differences in safety between males(N=382) and females(N=139) in the FLAGS study.
Nije bilo klinički relevantnih razlika u sigurnosti primjene između muškaraca(N=382) i žena(N=139) u FLAGS studiji.There were no clinically relevant differences observed for the safety profile of ALIMTA within the histology subgroups.
Nije bilo klinički značajnih razlika u sigurnosnom profilu lijeka ALIMTA između podskupina s različitim histološkim tipovima bolesti.There were no clinically relevant differences in pharmacokinetic properties between young children, children, adolescents and adults.
Nisu utvrđene klinički značajne razlike u farmakokinetičkim svojstvima između male djece, djece, adolescenata i odraslih.There are no clinically relevant differences in the rate of absorption when lixisenatide is administered subcutaneously in the abdomen, thigh, or arm.
Nema klinički značajnih razlika u brzini apsorpcije kada se liksisenatid primjenjuje supkutano u abdomen, bedro ili ruku.There were no clinically relevant differences observed for the safety profile of ALIMTA plus cisplatin within the histology subgroups.
Nisu uočene klinički značajne razlike u sigurnosnom profilu lijeka ALIMTA u kombinaciji s cisplatinom unutar podskupina prema histološkom tipu.There were no clinically relevant differences in empagliflozin pharmacokinetics between healthy volunteers and patients with type 2 diabetes.
Nije bilo klinički značajnih razlika u farmakokinetici empagliflozina između zdravih dobrovoljaca i bolesnika sa šećernom bolešću tipa 2.There were no clinically relevant differences observed for the safety profile of pemetrexed plus cisplatin within the histology subgroups.
Nije bilo klinički značajnih razlika u sigurnosnom profilu pemetrekseda u kombinaciji s cisplatinom unutar podskupina prema histološkom tipu.There are no clinically relevant differences in serum insulin or glucose levels after abdominal, deltoid or thigh administration of Lantus.
Nema klinički značajne razlike u koncentracijama inzulina niti glukoze u serumu nakon primjene inzulina glargina u abdomen, deltoidni mišić ili bedro.There were no clinically relevant differences between genders in the pharmacokinetics of lurasidone in a population pharmacokinetic analysis in patients with schizophrenia.
Nije bilo klinički relevantnih razlika među spolovima u farmakokinetici lurasidona u populaciji bolesnika sa shizofrenijom kod kojih je ispitivana farmakokinetika.There were no clinically relevant differences in incidence or severity of hypoglycaemia with exenatide compared to placebo, in combination with a thiazolidinedione, with or without metformin.
Nije bilo klinički značajne razlike u incidenciji i težini hipoglikemije pri primjeni eksenatida u odnosu na placebo u kombinaciji s tiazolidindionom, s metforminom ili bez njega.There are no clinically relevant differences in the pharmacokinetics of Ryzodeg between elderly and younger adult patients, between races or between healthy subjects and patients with renal or hepatic impairment.
Ne postoje klinički značajne razlike u farmakokinetici lijeka Ryzodeg između starijih osoba i mlađih odraslih bolesnika, između rasa ili između zdravih osoba i bolesnika s oštećenjem bubrega ili jetre.There were no clinically relevant differences between naloxegol 12.5 mg, 25 mg, and placebo in average pain intensity, daily opioid dose or in opioid withdrawal scores over the 12-week study.
Tijekom 12-tjednog ispitivanja nisu primijećene klinički značajne razlike između naloksegola u dozi od 12, 5 mg, naloksegola u dozi od 25 mg i placeba s obzirom na rezultate za prosječan intenzitet boli, dnevnu dozu opioida i ustezanje od opioida.There were no other clinically relevant differences between two concurrent injections of Xiapex in the same hand and up to three single injections of Xiapex in the types of adverse events reported ie, most adverse events were local to the treated extremity and of mild or moderate intensity.
Nije bilo drugih klinički važnih razlika u vrsti zabilježenih štetnih događaja između dvije injekcije Xiapexa istovremeno u istu šaku i do tri jednokratne injekcije Xiapexa tj. većina štetnih događaja bila je lokalna na liječenom ekstremitetu te blagog do umjerenog intenziteta.There was no clinically relevant difference in pharmacokinetics of Levemir between older and young subjects.
Nisu utvrđene klinički značajne razlike u farmakokinetici lijeka Levemir između starijih i mlađih ispitanika.
